Health Biotech Stock Roundup: NKTR Plunges on Deal Termination, REGN Offers Update & More April 20, 2022
Biotechnology FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis April 20, 2022
Biotechnology Alkermes Commences Arbitration Related to License Agreements with Janssen Pharmaceutica April 19, 2022
Biotechnology Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022 April 19, 2022
Search
biotech stock market
